Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025
Myriad Genetics (NASDAQ: MYGN) will release its third quarter 2025 financial results on November 3, 2025 after market close and will host an earnings conference call the same day at 4:30 PM ET. Management will provide a financial overview and business update for Q3 2025.
A live webcast will be available on Myriad’s Investor Relations website at investor.myriad.com. Telephone participants must register to receive a dial-in number and unique PIN. An archived webcast will be posted at investor.myriad.com following the call.
Myriad Genetics (NASDAQ: MYGN) diffonderà i risultati finanziari del terzo trimestre 2025 il 3 novembre 2025 dopo la chiusura del mercato e terrà la stessa giornata una conference call sui guadagni alle 4:30 PM ET. Il management fornirà una panoramica finanziaria e un aggiornamento sull’attività per Q3 2025.
Una trasmissione in diretta sarà disponibile sul sito di Relazioni con gli Investitori di Myriad all’indirizzo investor.myriad.com. I partecipanti telefonici devono registrarsi per ricevere un numero di accesso e un PIN univoco. Una trasmissione registrata sarà pubblicata su investor.myriad.com dopo la chiamata.
Myriad Genetics (NASDAQ: MYGN) publicará sus resultados financieros del tercer trimestre de 2025 el 3 de noviembre de 2025 después del cierre del mercado y celebrará una conferencia de ganancias el mismo día a las 4:30 PM ET. La dirección proporcionará una visión general financiera y una actualización comercial para el Q3 2025.
Una transmisión en vivo estará disponible en el sitio de Relaciones con Inversores de Myriad en investor.myriad.com. Los participantes por teléfono deben registrarse para recibir un número de marcación y un PIN único. Se publicará una transmisión archivada en investor.myriad.com tras la llamada.
Myriad Genetics (NASDAQ: MYGN)은 2025년 3분기 재무 결과를 2025년 11월 3일 장 마감 후 발표하고 같은 날 동시에 4:30 PM ET에 실적 컨퍼런스 콜을 주최합니다. 경영진은 Q3 2025에 대한 재무 개요 및 사업 업데이트를 제공합니다.
라이브 웹캐스트는 Myriad의 투자자 관계 웹사이트 investor.myriad.com에서 이용할 수 있습니다. 전화 참가자는 다이얼 인 번호와 고유 PIN을 받으려면 등록해야 합니다. 콜 이후에는 아카이브 웹캐스트가 investor.myriad.com에 게시됩니다.
Myriad Genetics (NASDAQ: MYGN) publiera ses résultats financiers du troisième trimestre 2025 le 3 novembre 2025 après la clôture du marché et organisera la même journée une conférence téléphonique sur les résultats à 16:30 ET. La direction fournira un aperçu financier et une mise à jour commerciale pour le T3 2025.
Une diffusion en direct sera disponible sur le site des Relations avec les investisseurs de Myriad à l’adresse investor.myriad.com. Les participants par téléphone doivent s’inscrire pour recevoir un numéro d’accès et un code PIN unique. Une diffusion enregistrée sera publiée sur investor.myriad.com après l’appel.
Myriad Genetics (NASDAQ: MYGN) wird seine Finanzergebnisse für das dritte Quartal 2025 am 3. November 2025 nach Börsenschluss bekannt geben und am selben Tag eine Ergebnis-Konferenzschaltung um 16:30 Uhr ET abhalten. Das Management wird einen finanziellen Überblick und ein Geschäftsupdate für Q3 2025 geben.
Eine Live-Übertragung wird auf der Investor Relations-Website von Myriad unter investor.myriad.com verfügbar sein. Telefonteilnehmer müssen sich registrieren, um eine Dial-in-Nummer und eine eindeutige PIN zu erhalten. Eine archivierte Webcast wird nach der Call auf investor.myriad.com veröffentlicht.
Myriad Genetics (NASDAQ: MYGN) ستعلن عن نتائجها المالية للربع الثالث من 2025 في 3 نوفمبر 2025 بعد إغلاق السوق وستعقد مكالمة مؤتمر للنتائج في نفس اليوم عند 4:30 مساءً بتوقيت شرق الولايات المتحدة. ستقدّم الإدارة لمحة مالية وتحديثًا عن الأعمال للربع الثالث 2025.
سيكون هناك بث مباشر على موقع علاقات المستثمرين لشركة Myriad على investor.myriad.com. يجب على المشاركين عبر الهاتف التسجيل للحصول على رقم وصول وPIN فريد. سيتم نشر بث مسجل على investor.myriad.com بعد انتهاء المكالمة.
Myriad Genetics (NASDAQ: MYGN) 将在市场收盘后公布其 2025 年度第三季度 财务业绩，时间为 2025 年 11 月 3 日，并将在同一天举行 美东时间 4:30 PM 的盈利电话会议。管理层将提供 2025 第三季度的财务概览和业务更新。
现场网络广播将在 Myriad 的投资者关系网站 investor.myriad.com 提供。电话参与者必须注册以获得拨入号码和唯一 PIN。通话结束后，存档广播将发布在 investor.myriad.com。
- None.
- None.
SALT LAKE CITY, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third quarter 2025 earnings conference call at 4:30 pm ET on Monday, Nov. 3, 2025. The company’s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company’s performance for the third quarter 2025.
A live webcast of the conference call can be accessed on Myriad’s Investor Relations website at investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An archived webcast of the call will be available at investor.myriad.com following the call.
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com
Media Contact
Kate Schraml
(224) 875-4493
PR@myriad.com
FAQ
When will Myriad Genetics (MYGN) release its Q3 2025 earnings and hold the conference call?
How can investors access the Myriad Genetics (MYGN) Q3 2025 earnings webcast?
Can I join the Myriad Genetics (MYGN) earnings call by phone and what is required?
What will Myriad management cover during the Q3 2025 earnings call for MYGN?
Where will the archived Myriad Genetics (MYGN) Q3 2025 earnings call be posted?
